Understanding reproductive counseling for patients with skin genetic disorders
Official title: Investigating Perspectives of Patients With Genodermatosis and Healthcare Professionals on Reproductive Counselling
Run by Maastricht University Medical Center · NCT06330350 · Data updated 2026-11-12
This study is trying to understand how people with skin genetic disorders and their partners make decisions about having children, while also looking at what doctors know and think about these choices.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Maastricht University Medical Center Academic / other |
| Locations | 1 site (Maastricht, Limburg) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | August 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | May 18, 2025 |
| Trial ID | NCT06330350 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adult patients with confirmed genodermatosis who wish to have children, along with their partners.
✕Probably not a fit
Patients who cannot communicate verbally in Dutch or English will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather insights from patients with genodermatoses and their partners regarding their reproductive decision-making processes. It will also explore the knowledge and perspectives of healthcare professionals involved in their care. Individual semi-structured qualitative interviews will be conducted to capture the experiences and needs of both patients and clinicians. The goal is to identify gaps in information and support related to reproductive options for affected individuals.
Why it matters
Potential benefit: If successful, this study could enhance reproductive counseling and support for patients with genodermatoses, leading to better-informed decisions about family planning.
How similar studies have gone: While qualitative studies on reproductive counseling exist, this specific focus on genodermatoses is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients with genodermatosis (i.e, keratinisation disorders, skin fragility diseases, ectodermal dysplasias, dermato-oncological syndromes, other genodermatoses) and a desire to have children, with if applicable his or her partner with a desire to have children * Patients with clinically and molecularly confirmed variant of a genodermatosis * Health care professionals involved with the care of genodermatology patients (e.g. clinical geneticists, dermatologists) Exclusion Criteria: * Not being able to communicate verbally in Dutch or English
Where it's running
-
Maastricht University Medical Center
Maastricht, Limburg, Netherlands Recruiting
Study contacts
- Principal investigator: Antoni Gostynski, MD, PhD — Maastricht University Medical Center
- Study coordinator: Fauve C van Veen, MD
- Email: genodermatose@mumc.nl
- Phone: +31433877293
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Assessing the burden of rare skin diseases
This study is trying to understand how nine rare skin diseases affect the daily lives of patients and their families, including their emotional, social, and financial challenges.
-
Ulthera System for skin laxity in the lower face, chin, and neck
This study tests whether the Ulthera System can improve loose skin under the chin and on the neck compared with not treating it.
-
3-D printed versus conventional overdentures for people with ectodermal dysplasia
This project will test whether 3-D printed overdentures provide better fit, comfort, and satisfaction than conventional acrylic overdentures for people aged 10–35 with ectodermal dysplasia who have some remaining upper teeth.
-
Oleogel-S10 gel for healing skin wounds in Japanese patients with epidermolysis bullosa.
We will try Oleogel‑S10 gel to see if it closes or shrinks wounds in Japanese children and adults with junctional or dystrophic epidermolysis bullosa.
-
Using IV immunoglobulin to lower collagen VII antibodies in dystrophic epidermolysis bullosa
This trial tests whether IV immunoglobulin given to people with recessive dystrophic epidermolysis bullosa who are on VYJUVEK helps wounds heal faster and lowers collagen VII and HSV‑1 antibody levels.
-
Understanding genetic causes of neuroendocrine tumors in Mexican patients
This study is trying to find out the genetic changes that cause neuroendocrine tumors in Mexican patients to help develop better treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.